RxDoctor Payments Data

Nadine Brock, APRN

Nurse Practitioner · London, KYNPI 1285800938

Payments from drug & device makers

$528in general payments, 2019–2025

Across 30 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$101
  • Pfizer$81
  • AbbVie$71
  • Otsuka America Pharmaceutical, Inc.$56
  • Xeris Pharmaceuticals, Inc.$39
  • GSK$26
  • plus $154 from 8 others

What the payments were for

  • Food & beverage$528100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$528 in reported general payments places this provider in the 55th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$40,312
Medicare patients
41
Services billed
904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide190$245,189
OzempicSemaglutide77$101,054
Tresiba Flextouch U-200Insulin Degludec43$50,105
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$42,137
LinzessLinaclotide30$21,531
TrulicityDulaglutide14$20,951
Breo ElliptaFluticasone/Vilanterol31$19,695
XareltoRivaroxaban26$19,582
EliquisApixaban22$17,116
Nurtec OdtRimegepant Sulfate13$15,807
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$8,637
Albuterol Sulfate HfaAlbuterol Sulfate63$3,042
Ventolin HfaAlbuterol Sulfate41$2,880
Megestrol Acetate19$2,114
Levothyroxine Sodium179$1,890

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$18$266,140204 claims
Novo NordiskOzempic$101$101,05477 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$26$70,46988 claims
PfizerEliquis, Nurtec Odt$81$32,92335 claims
AbbVieLinzess, Synthroid$71$22,20944 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →